CRISPR2
Live / Registered — Registered (as of 16 May 2023)
What this means for you
Registered since 16 May 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88765574
- Registration number
- 7055692
- Mark type
- Word mark
- Filed
- 20 Jan 2020
- Published for opposition
- 11 Aug 2020
- Registered
- 16 May 2023
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 042 — Scientific and technological services: Drug discovery services; Laboratory research services relating to pharmaceuticals; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields
Owner
- KSQ Therapeutics, Inc., Cambridge, MA, US
- KSQ Therapeutics, Inc., Cambridge, MA, US
- KSQ Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 16 May 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 May 2023 — REGISTERED-PRINCIPAL REGISTER
- 13 Apr 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Apr 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 11 Apr 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Apr 2023 — USE AMENDMENT FILED
- 06 Apr 2023 — TEAS STATEMENT OF USE RECEIVED
- 10 Dec 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Dec 2022 — SOU EXTENSION 4 GRANTED
- 06 Oct 2022 — SOU EXTENSION 4 FILED
- 09 Dec 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Nov 2022 — NOTICE OF REVIVAL - E-MAILED
- 08 Nov 2022 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 08 Nov 2022 — PETITION TO REVIVE-GRANTED
- 08 Nov 2022 — TEAS PETITION TO REVIVE RECEIVED